| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $29.8M | +340.1% |
| Cost of Revenue | $4.0M | -14.6% |
| R&D Expense | $77.8M | +77.6% |
| SG&A Expense | $25.1M | +6.4% |
| Operating Income | -$89.9M | -0.1% |
| Pre-tax Income | -$86.9M | +4.4% |
| Income Tax | -$182K | — |
| Net Income | -$86.9M | +4.4% |
| EPS (Basic) | -$1.33 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.3M | +65.6% |
| Accounts Receivable | $484K | -22.3% |
| Current Assets | $231.6M | +12.9% |
| Total Assets | $254.6M | +1.3% |
| Current Liabilities | $21.9M | -4.3% |
| Total Liabilities | $57.0M | +5.8% |
| Stockholders' Equity | $197.6M | +0.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.6M | -29.6% |
| Capital Expenditures | $605K | +96.4% |
| Investing Cash Flow | $12.6M | +107.5% |
| Financing Cash Flow | $72.9M | -67.6% |
| Free Cash Flow | -$68.2M | -30.0% |
| +16.9% |
| EPS (Diluted) | -$1.33 | +16.9% |